Interpretation of an Extended Autoantibody Profile in a Well-Characterized Australian Systemic Sclerosis (Scleroderma) Cohort Using Principal Components Analysis
KA Patterson, PJ Roberts-Thomson, S Lester, JA Tan, P Hakendorf, M Rischmueller, J Zochling, J Sahhar, P Nash, J Roddy, C Hill, M Nikpour, W Stevens, SM Proudman, JG Walker
Arthritis & Rheumatology | WILEY | Published : 2015
Supported by a donation from Euroimmun (Lubeck, Germany) for the line immunoblot instrument, SSc profile kits, and flatbed scanner. The SSc patients were recruited as part of the Australian Scleroderma Cohort Study, which is managed by the Australian Scleroderma Interest Group and is supported by St. Vincent's Hospital IT Department and Research Endowment Foundation, Scleroderma Australia, Arthritis Australia, and unrestricted educational grants from Actelion Australia, GlaxoSmithKline, and Pfizer.